Clinical trial
Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma
NCT00006249 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Unknown status
Key facts
| NCT number | NCT00006249 |
|---|---|
| Title | Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma |
| Official title | PEG-Intron Observation After Regional Lymph Node Dissection in AJCC Stage III (TxN1-2MO) Melanoma Patients: a Randomized Phase III Trial |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological, Procedure |
| Interventions | pegylated interferon alfa, adjuvant therapy |
| Enrollment | 1,258 |
| Start date | Jun 1, 2000 |
| Primary completion | Aug 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 10, 2015 |
| Countries | Australia, Belgium, Bulgaria, Croatia, Czechia, Estonia, France, Germany, Israel, Italy, Netherlands, Poland and 6 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: